Investing Made Simple
🥱 Dec inflation hits 7%. Dec 12-month CPI hit 7% up from Nov’s 6.8% reading. Viewing #InflationFears potentially moderating, investors initially cheered results Wed though optimism lost stream by end of day. 🧐 Stagnant market. Markets struggling for direction as investors remain focused on #RisingYields. Some analysts now predicting 4 rate hikes this year while Fed trying to soothe markets Read More
💨👟 Fleeing growth. 2022 started right where 2021 ended with fear around lofty Growth valuations in a #RisingYields environment. While overall S&P 500 down -2% for week, heavy #Flight2Safety Value rotation all week with Growth underperforming Value by over 5%. 📝 Hawkish Fed minutes. Compounding already negative Growth sentiment, Fed Dec meeting notes released indicate quicker balance sheet reduction under consideration Read More
Market Musings 1/6/2022 Quick thoughts on the markets and major portfolio news. Not on Ursa yet? Download Ursa from the App Store! #RisingYields likely to be major 2022 trend. We believe Fed gets more hawkish than current plans as indicated by recently released minutes. Updated January 7, 2021 Massive #Flight2Safety value rotation first week into Read More
🦅 Fed shifting to offense. Fed turns hawkish to combat surging #InflationFears. Fed accelerating tapering plan doubling monthly reduction to $30B and targeting 3 rate hikes in 2022 (up from just one expected last month). We think even the accelerated expectations may still be conservative… 😷 Omicron surging globally. While still milder symptoms generally, high transmissibility has #COVID19 Omicron surging Read More
😅 Omicron fears abating. Positive developments on the #COVID19 Omicron front has the market running. Cases so far seem mild with high transmissibility and Pfizer believes its 3-shot regimen (2 initial + 1 booster) protects against Omicron. 🙄 CPI up only 6.8%… Nov 12-month CPI grew 6.8%－a 40-year high. However, markets actually cheered the news with CPI coming in below #InflationFears estimate of Read More
😬 Omicron anxiety. Big market movements all week with small bits of #COVID19 Omicron news trickling out. Investors remain super anxious with #COVIDRecovery uncertainty from new variant. S&P 500 ends down -1% for week. 💸 Transient no more? Powell is retiring describing inflation as ‘transient’ and considering accelerating asset tapering timeline. Quick tone change from just a couple weeks ago signaling #InflationFears risk Read More
Market Musings 12/2/2021 Quick thoughts on the markets and major portfolio news. Not on Ursa yet? Download Ursa from the App Store! Market rollercoaster since Omicron news broke Black Friday. We’re closely monitoring severity of symptoms, transmissibility and potential vaccine immunity for signal on #COVIDRecovery. It was a different Black Friday than we were expecting. Read More
🛍 Strong retail spending. Retail #earnings were strong highlighting #COVIDRecovery consumer demand remains intact despite #InflationFears. However, #SupplyScare issues remain heading into Q4. Consumer up +4% for week. 🦠 4th Wave? #COVID19 resurgence in Europe as rising case has Austria mandating 20-day lockdown and Germany not ruling out potential lockdown either. Even cases troughed weeks ago and rising again. Volatile market as #COVIDRecovery keeps starting and stopping. ️💸 Read More
📈 Surging inflation. #InflationFears in high gear with Oct 12-month CPI rising 6.2%－3x higher than 2% annual target. Investors concerned Fed moving too slow with stubborn ‘transient’ expectations. 10-year treasury yield rebounds up +9% after pullback from conservative Fed action. 📉 Consumer sentiment falling. #InflationFears spilling onto Mainstreet. Michigan’s consumer sentiment gauge dropped to 10-year low driven by surging Read More
🦥 Cautious Fed. As expected, Fed starting to taper asset purchases by $15B/month. However, Fed remains steadfast in transient #InflationFears expectations tempering rate hike forecast. 10-year treasury yield fell -7% during the week with Financials 🏦 lower with it. ✈️ Travel time. #RevengeTravel got a shot in the arm with more positive #COVID19 pill data. Compounds strong #earnings as travel restrictions ease globally. All 👀 on Read More